Bayer and Boehringer Ingelheim Vetmedica have signed an agreement under which Bayer would acquire Boehringer’s Cydectin bovine and ovine endectocide products in the U.S. Once completed, the deal would include the transfer of Cydectin Pour-On, Cydectin Injectable and Cydectin Oral Drench. These endectocides with the active ingredient moxidectin offer persistent killing of internal parasites at multiple stages, including the most economically devastating parasite, Ostertagia ostertagi (brown st...